Skechers, known for its comfortable and affordable sneakers, agreed to a $9.4 billion deal to be taken private by 3G Capital.
Our daily email brings you smart and engaging news and analysis on the biggest stories in business and finance. For free.
Suppliers are upset Temu is swapping to a more Amazon-esque supplier model and trying to drive prices ever-downward.
Vitol Group, the world’s largest independent oil trader, has paid around a record $6.4 billion in share buybacks to its employee-owners.
McDonald’s warned that customers might be getting sick of price hikes. It was right. Sales fell year-over-year for the first time since 2020.
President Trump wants to bring film-making back to Hollywood by imposing 100% tariffs on movies produced outside of the US.
Pioneering online education company 2U filed for bankruptcy, even as the public writ large has gradually embraced online learning.
Taylor Swift may be signed to the label, but Universal Music Group somehow can’t find a way to make its business work.
A patent for generative neural network-based ultrasounds from medical device firm Philips could provide more data to develop AI innovations throughout…
The delay of Grand Theft Auto VI’s release threw a multibillion dollar wrench in forecasted revenues for a gaming industry in need of a hit.
General Motors shares tumbled after the company said its driverless taxi division, Cruise, will suspend production of the Origin robotaxi.
Shell has started to shop around for buyers to offload its stake in an offshore wind project off the coast of Scotland.
Ryanair said it had seen its profits take a 46% nosedive, and would have to offer “materially lower” airfares for the busy summer period.
Coca-Cola was one of several companies whose earnings last week flashed positive signs, despite the hail of uncertainty around tariffs.
It was only last year that 737 felt like the number of scandals Boeing was embroiled in, rather than the name of its narrow-body aircraft.
US President Donald Trump is reportedly considering linking prescription drug prices to their price tags in other developed nations.
Three titans of the US defense industry — Lockheed Martin, RTX, and Northrop Grumman — signalled tariffs are going to be bad for business.